Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-27 Purchase |
2024-12-31 4:05 pm |
Passage BIO Inc. | PASG | Lynx1 Capital Management LP Nichols Weston 10% Owner |
373,645 | $0.6451 | $241,038 | 9,256,953 (Indirect) |
View |
| 2024-12-12 Purchase |
2024-12-16 4:26 pm |
TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner |
131,800 | $2.9269 | $385,769 | 5,357,347 (Indirect) |
View |
| 2024-11-25 Purchase |
2024-11-27 6:11 pm |
Passage BIO Inc. | PASG | Lynx1 Capital Management LP Nichols Weston 10% Owner |
456,353 | $0.62346 | $284,520 | 8,883,308 (Indirect) |
View |
| 2024-11-15 Purchase |
2024-11-19 4:26 pm |
TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner |
947 | $4.3442 | $4,114 | 5,225,547 (Indirect) |
View |
| 2023-05-31 Sale |
2023-06-02 5:35 pm |
TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner |
25,400 | $2.5178 | $63,953 | 5,224,600 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2024-08-09 5:11 pm |
N/A N/A |
Passage BIO Inc. | PASG | Lynx1 Capital Management LP Nichols Weston 10% Owner |
0 | $0 | 8,426,955 (Indirect) |
View |
| 2024-06-07 Option Award |
2024-06-11 4:20 pm |
N/A 2034-06-07 |
Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director |
15,900 | $0 | 21,900 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 5:00 pm |
N/A 2033-06-15 |
Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director |
23,500 | $0 | 23,500 (Direct) |
View |
Ownership |
2023-06-02 5:33 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner |
0 | $0 | 5,250,000 (Indirect) |
View |
| 2022-06-17 Option Award |
2022-06-21 4:46 pm |
N/A 2032-06-16 |
Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-06-22 Option Award |
2021-06-23 5:00 pm |
N/A 2031-06-21 |
Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2020-06-19 Option Award |
2020-06-22 4:20 pm |
N/A 2030-06-18 |
Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director |
12,500 | $0 | 12,500 (Direct) |
View |